Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Polylite Taiwan Co., Ltd. (1813:TWSE), powered by AI.
Polylite Taiwan Co., Ltd. is currently trading at $11.85. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Polylite Taiwan Co., Ltd. on Alpha Lenz.
View Polylite Taiwan Co., Ltd.'s valuation metrics on Alpha Lenz.
“Polylite Taiwan Co., Ltd.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Polylite Taiwan Co., Ltd. is a manufacturer and global supplier specializing in optical lenses and related equipment. Established in 1982 and headquartered in Taoyuan City, Taiwan, the company focuses on the processing, manufacturing, import, export, and sale of a diverse range of lens products, including polycarbonate lenses such as FSV (Finished Single Vision), SFSV (Semi-Finished Single Vision), progressive, KID, and polarized lenses. Polylite Taiwan serves various markets by supplying lenses and optical components that support both consumer eyewear and specialized medical equipment. The company is notably active in the healthcare sector, particularly within the categories of health care supplies and medical equipment, and has established a presence in key international markets, with significant sales generated in both the United States and Taiwan. Through continual research and development, Polylite Taiwan contributes advanced manufacturing technology to the optical industry, addressing evolving needs in vision care and medical optics. With decades of operational history and a broad product portfolio, the company plays a meaningful role in the regional and global supply chains for healthcare equipment and optical solutions.
“Polylite Taiwan Co., Ltd.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Polylite Taiwan Co., Ltd. (ticker: 1813) is a company listed on TWSE in the Technology sector (Semiconductors).
The current price is 11.85 with a P/E ratio of -x and P/B of -x.
ROE is -6.81% and operating margin is -41.82%. Annual revenue is $304M.